$9.05
1.57% today
Nasdaq, Dec 30, 10:00 pm CET
ISIN
US03475V1017
Symbol
ANGO

AngioDynamics, Inc. Target price 2024 - Analyst rating & recommendation

AngioDynamics, Inc. Classifications & Recommendation:

Buy
100%

AngioDynamics, Inc. Price Target

Target Price $13.00
Price $8.91
Potential
Number of Estimates 3
3 Analysts have issued a price target AngioDynamics, Inc. 2025 . The average AngioDynamics, Inc. target price is $13.00. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 3 analysts: 3 Analysts recommend AngioDynamics, Inc. to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the AngioDynamics, Inc. stock has an average upside potential 2025 of . Most analysts recommend the AngioDynamics, Inc. stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
May '24 2025
Estimates
Revenue Million $ 303.91 283.86
10.28% 6.60%
EBITDA Margin -2.01% -0.11%
146.89% 94.52%
Net Margin -61.92% -13.58%
284.68% 78.07%

3 Analysts have issued a sales forecast AngioDynamics, Inc. 2025 . The average AngioDynamics, Inc. sales estimate is

$284m
Unlock
. This is
3.03% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$284m 2.91%
Unlock
, the lowest is
$283m 3.19%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $304m 10.28%
2025
$284m 6.60%
Unlock
2026
$304m 7.25%
Unlock
2027
$332m 8.96%
Unlock
2028
$363m 9.35%
Unlock
2029
$395m 9.02%
Unlock

1 Analyst has issued an EBITDA forecast AngioDynamics, Inc. 2025 . The average AngioDynamics, Inc. EBITDA estimate is

$-300k
Unlock
. This is
94.02% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-300k 94.02%
Unlock
, the lowest is
$-300k 94.02%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $-6.1m 142.07%
2025
$-300k 95.08%
Unlock
2026
$7.4m 2,566.67%
Unlock
2027
$34.7m 368.92%
Unlock
2028
$56.6m 63.11%
Unlock
2029
$68.3m 20.67%
Unlock

EBITDA Margin

2024 -2.01% 146.89%
2025
-0.11% 94.52%
Unlock
2026
2.43% 2,309.09%
Unlock
2027
10.46% 330.45%
Unlock
2028
15.61% 49.24%
Unlock
2029
17.27% 10.63%
Unlock

2 AngioDynamics, Inc. Analysts have issued a net profit forecast 2025. The average AngioDynamics, Inc. net profit estimate is

$-38.5m
Unlock
. This is
84.44% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-32.0m 87.09%
Unlock
, the lowest is
$-45.1m 81.79%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-188m 245.11%
2025
$-38.5m 79.52%
Unlock
2026
$-29.7m 22.86%
Unlock
2027
$-2.1m 93.10%
Unlock
2028
$10.7m 620.00%
Unlock
2029
$15.2m 42.31%
Unlock

Net Margin

2024 -61.92% 284.68%
2025
-13.58% 78.07%
Unlock
2026
-9.76% 28.13%
Unlock
2027
-0.62% 93.65%
Unlock
2028
2.94% 574.19%
Unlock
2029
3.84% 30.61%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
May '24 2025
Estimates
Earnings Per Share $ -4.59 -0.94
245.11% 79.52%
P/E negative
EV/Sales 1.10

2 Analysts have issued a AngioDynamics, Inc. forecast for earnings per share. The average AngioDynamics, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-0.94
Unlock
. This is
84.44% higher
Unlock
than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-0.78 87.09%
Unlock
, the lowest is
$-1.10 81.79%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-4.59 245.11%
2025
$-0.94 79.52%
Unlock
2026
$-0.73 22.34%
Unlock
2027
$-0.05 93.15%
Unlock
2028
$0.26 620.00%
Unlock
2029
$0.37 42.31%
Unlock

P/E ratio

Current -1.48 102.84%
2025
-9.48 540.54%
Unlock
2026
-12.29 29.64%
Unlock
2027
-178.20 1,349.96%
Unlock
2028
34.27 119.23%
Unlock
2029
24.08 29.73%
Unlock

Based on analysts' sales estimates for 2025, the AngioDynamics, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.07 38.96%
2025
1.10 2.87%
Unlock
2026
1.03 6.75%
Unlock
2027
0.94 8.22%
Unlock
2028
0.86 8.55%
Unlock
2029
0.79 8.28%
Unlock

P/S ratio

Current 1.24 30.98%
2025
1.28 3.12%
Unlock
2026
1.19 6.75%
Unlock
2027
1.09 8.22%
Unlock
2028
1.00 8.55%
Unlock
2029
0.92 8.26%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today